CytomX Therapeutics Inc. (CTMX) slipped -6.46% or -1.64 to $23.76. It is close to 135608 shares traded, which is 28.93% compare to the average total volume 468779. The market cap of CTMX is $1.05 billion. The year to date change is 10.27%. The 52 week price range is from $13.48 to $35.0. Price of CTMX have changed -0.97% during last week. It have changed 1.36% over last month, 2.88% over last 3 months, -9.29% over last 6 months and 86.08% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CTMX is 24.69. It is 3.91% above current price. The 200-day Moving Averages for CTMX is 25.19. It is 6.02% above current price. The 52-week High is 35.0. It is 47.31% from the current price. The 52-week Low is 13.48. It is -43.27% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of CTMX is 4.92 on 2018-07-13. Short % to float is 6.19%. There are some statistics of CTMX. It is has market cap $1.05 billion. The share outstanding is 44.06 million. The average volume is 468779. The revenue is 32.90M. The percent of top 15 Institution holding is 71.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CTMX is -74.55%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CTMX is -17.29%.